Mitchell Cancer Institute, University of South Alabama, Mobile, AL, USA.
Adv Exp Med Biol. 2019;1152:1-7. doi: 10.1007/978-3-030-20301-6_1.
Breast Cancer is the leading cancer, in terms of incidence, that affects women. Better prognosis is still associated with detection at early stages, resulting in increased emphasis on timely and improved screening strategies. More data is now available on the incidence as well as mortality of almost all cancers, including breast cancer. This article discusses the trends in incidence as well as mortality of breast cancer in the US over last ten reportings i.e. years 2009 through 2018, along with an overview of recently reported numbers globally. The incidence rate is clearly on rise, which is indicative of aggressive screenings and detections. The mortality rate has not increased at the same pace, suggesting better clinical management of breast cancer patients, but the numbers are still too high. While screenings and early diagnoses should still be a point of focus, particularly in developing and poor countries, more efforts are needed to improve the prognosis of patients diagnosed at a later stage.
乳腺癌是女性发病率最高的癌症。更好的预后仍然与早期发现有关，因此更加重视及时和改进的筛查策略。现在有更多关于几乎所有癌症（包括乳腺癌）发病率和死亡率的数据。本文讨论了过去十年（即 2009 年至 2018 年）美国乳腺癌发病率和死亡率的趋势，并概述了全球最近报告的数字。发病率显然呈上升趋势，这表明筛查和检测更加积极。死亡率并没有以同样的速度增加，这表明乳腺癌患者的临床管理得到了改善，但数字仍然过高。虽然筛查和早期诊断仍然应该是重点，但特别是在发展中国家和贫困国家，还需要做出更多努力来改善晚期诊断患者的预后。
